NCT00742833View on ClinicalTrials.gov

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

Not specified

Conditions
Overactive Bladder (OAB)
Interventions
DRUG

KUC-7483

DRUG

Placebo

Trial Locations (6)

Unknown

Japan, Hokkaido Region

Japan, Kansai Region

Japan, Kanto Region

Japan, Kyushu Region

Japan, Shikoku Region

Japan, Tohoku Region

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY